However, considering the down-regulation of FOXM1 and CXCR4 expression level in breast tissues after IER intervention, we speculated that FOXM1 and CXCR4 might be the most important key genes in reducing the risk of postmenopausal BC after IER intervention. The gene discussed is FOXM1; the disease is breast cancer.